Last reviewed · How we verify
Povidone-Iodine 10%
Povidone-Iodine 10% is a Antiseptic [EPC] Small molecule drug developed by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. It is currently FDA-approved for Prevention of infection in minor cuts and burns. Also known as: Profend.
Povidone-Iodine 10%, marketed by Cliniques universitaires Saint-Luc- Université Catholique de Louvain, is an antiseptic solution primarily indicated for the prevention of infection in minor cuts and burns. The drug's key strength lies in its well-established mechanism and broad acceptance in the market, with a key composition patent expiring in 2028. The primary risk is the potential increase in competition as the patent expiration approaches, which could impact market share and revenue.
At a glance
| Generic name | Povidone-Iodine 10% |
|---|---|
| Also known as | Profend |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Drug class | Antiseptic [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
- Prevention of infection in minor cuts and burns
Common side effects
Key clinical trials
- Surgical Site Preparation in Subjects Undergoing Medical Thoracoscopy (NA)
- Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder (NA)
- Preoperative Clindamycin Vaginal Cream Versus Vaginal Cleansing With Povidone-iodine on Postoperative Infections After Cesarean Section (PHASE4)
- CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee (NA)
- The Additive Effect of Exercise in Addition to Corticosteroid Injection in Plantar Fasciitis (NA)
- Povidone Iodine Efficacy Study (PHASE2)
- The Efficacy of Wet Cupping Therapy on Cerebral Oxygenation (NA)
- Efficacy of Transversus Abdominis Plane Block in Alleviating Acute Appendicitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Povidone-Iodine 10% CI brief — competitive landscape report
- Povidone-Iodine 10% updates RSS · CI watch RSS
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain portfolio CI
Frequently asked questions about Povidone-Iodine 10%
What is Povidone-Iodine 10%?
What is Povidone-Iodine 10% used for?
Who makes Povidone-Iodine 10%?
Is Povidone-Iodine 10% also known as anything else?
What drug class is Povidone-Iodine 10% in?
What development phase is Povidone-Iodine 10% in?
Related
- Drug class: All Antiseptic [EPC] drugs
- Manufacturer: Cliniques universitaires Saint-Luc- Université Catholique de Louvain — full pipeline
- Indication: Drugs for Prevention of infection in minor cuts and burns
- Also known as: Profend
- Compare: Povidone-Iodine 10% vs similar drugs
- Pricing: Povidone-Iodine 10% cost, discount & access